SARMs Control Act of 2018
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Selective Androgen Receptor Modulators Control Act of 2018 or the SARMs Control Act of 2018
This bill amends the Controlled Substances Act (CSA) to add SARMs (selective androgen receptor modulators) to schedule III. A SARM is a synthetic drug or substance that has effects similar to testosterone. A schedule III controlled substance (e.g., an anabolic steroid) has less potential for abuse than a schedule I or II substance, has a currently accepted medical use, and has low or moderate risk of dependence if abused.
The bill also:
- authorizes, and establishes procedures for, the Drug Enforcement Administration (DEA) to temporarily and permanently add a drug or substance to the definition of a SARM;
- specifies that a felony drug offense includes an offense related to SARMs; and
- makes it unlawful to import, export, manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense, a SARM that is not clearly labeled.
The bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to notify the DEA when it determines that a new dietary ingredient in a dietary supplement may contain a SARM or SARM analogue.
Read twice and referred to the Committee on the Judiciary.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2742: SARMs Control Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-S-2742/
"S. 2742: SARMs Control Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2742/.
S. 2742, 115th Cong. (2026), https://openamerica.io/bill/115-S-2742/.
[S. 2742: SARMs Control Act of 2018](https://openamerica.io/bill/115-S-2742/)